نتایج جستجو برای: kdoqi

تعداد نتایج: 198  

Journal: :Rhode Island medical journal 2014
Maroun Azar

Chronic Kidney Disease (CKD) is widely prevalent in the elderly population. The recent "Kidney Disease: Improving Global Outcomes (KDIGO) 2012 Clinical Practice Guideline on the Evaluation and Management of CKD" builds on the previous Kidney Disease Outcomes Quality Initiative (KDOQI) guideline and addresses many of its gaps. However, older adults with CKD have unique characteristics that may n...

2012
Melissa S. Nolan Amber S. Podoll Anne M. Hause Katherine M. Akers Kevin W. Finkel Kristy O. Murray

INTRODUCTION In experimental models of West Nile virus (WNV) infection, animals develop chronic kidney infection with histopathological changes in the kidney up to 8-months post-infection. However, the long term pathologic effects of acute infection in humans are largely unknown. The purpose of this study was to assess renal outcomes following WNV infection, specifically the development of chro...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2013
Pierre Delanaye Hans Pottel Rossini Botev Lesley A Inker Andrew S Levey

The best overall index of renal function is the glomerular filtration rate (GFR) [1]. Since measuring the GFR can be cumbersome and costly, estimation of GFR is essential for the diagnosis and evaluation of chronic kidney disease (CKD), defined as kidney damage or GFR <60 niL/min/1.73 m 2 for ≥3 months and staged by levels of GFR according to the NKF KDOQI (The National Kidney Foundation Kidney...

Journal: :Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 2012
Nahla A Al-Ageel Sinaa A Al-Aqeel Norah O Abanmy Jamal S Alwakeel Alaa Sabry Khalid A Alsaran

UNLABELLED The anemia of end stage renal disease (ESRD) is common and often severe complication that can be managed successfully by erythropoiesis-stimulating agents (ESA) administration. AIMS To investigate current practice of anemia management in hemodialysis patients and to assess the appropriateness of anemia management by comparing observed practice to the Kidney Disease Outcomes Quality...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007
Edmund J Lamb Alex Hodsman Dirk van Schalkwyk David Ansell Graham Warwick

In the UK, there is a continuing year-on-year trend towards improvement in serum phosphate control in dialysis patients although overall it still remains poor. The Renal Association (RA) target (<1.8 mmol/l) was achieved in 65% of patients overall, (71% of peritoneal dialysis (PD) patients, 63% of haemo dialysis (HD) patients). Seventy-six percent of UK dialysis patients achieve a corrected cal...

Journal: :Nephron. Clinical practice 2010
Stein Ivar Hallan Stephan Reinhold Orth

The worldwide high prevalence of chronic kidney disease (CKD) and the increasing number of patients reaching end-stage renal disease (ESRD) are a matter of major concern. The most widely accepted classification system of CKD is that proposed by the Kidney Disease Outcomes Quality Initiative (KDOQI) in 2002. When applying this system, it has become apparent that the prevalence of CKD is particul...

Journal: :European review for medical and pharmacological sciences 2014
S Lai A Mariotti B Coppola C Lai P Aceto M Dimko A Galani G Innico N Frassetti M Mangiulli R Cianci

BACKGROUND Patients with chronic kidney disease (CKD) show a risk of cardiovascular death, which is 10-100 times higher than that in the general population. This increase is not completely explained by the traditional cardiovascular risk factors. Hyperuricemia and hyperhomocysteinemia are highly prevalent in CKD. Patients suffering from these complications present accelerated atherosclerosis, d...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید